Ratings by Stifel (James Condulis)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Arrowhead Pharma | ARWR | New Coverage | Buy (N/A) |
76.40 (74.30) |
-2.75% | Details | |
| 6/2/2026 | Fulcrum Therapeutics | FULC | Downgrade | Hold (Buy) |
6.92 (3.65) |
-47.25% | Details | |
| 5/7/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Tectonic Therapeutics Inc. | TECX | New Coverage | Buy (N/A) |
30.72 (32.60) |
6.12% | Details | |
| 4/7/2026 | Soleno Therapeutics Inc. | SLNO | Downgrade | Hold (Buy) |
39.49 (53.01) |
34.24% | Details | |
| 3/24/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2026 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Amylyx Pharmaceuticals inc. | AMLX | New Coverage | Buy (N/A) |
15.17 (17.75) |
17.01% | Details | |
| 3/2/2026 | Aardvark Therapeutics Inc | AARD | Downgrade | Hold (Buy) |
12.50 (5.86) |
-53.12% | Details | |
| 2/26/2026 | Edgewise Therapeutics | EWTX | Maintain | Hold (N/A) |
|
Details | ||
| 2/26/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 12/16/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2025 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
3.25 (3.82) |
17.54% | Details | |
| 11/14/2025 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (Buy) |
|
Details | ||
| 11/5/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2025 | Aardvark Therapeutics Inc | AARD | New Coverage | Buy (N/A) |
12.67 (12.50) |
-1.34% | Details | |
| 9/24/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 9/2/2025 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Mirum Pharmaceuticals | MIRM | New Coverage | Buy (N/A) |
59.97 (118.86) |
98.2% | Details | |
| 8/7/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 7/10/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 7/7/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Edgewise Therapeutics | EWTX | Maintain | Hold (N/A) |
|
Details | ||
| 6/12/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Buy (Buy) |
|
Details | ||
| 6/10/2025 | NewAmsterdam Pharma Co NV | NAMS | New Coverage | Buy (N/A) |
20.14 (31.68) |
57.3% | Details | |
| 5/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 4/21/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2025 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | Soleno Therapeutics Inc. | SLNO | New Coverage | Buy (N/A) |
44.44 (39.49) |
-11.14% | Details | |
| 2/18/2025 | Cytokinetics | CYTK | Maintain | Buy (Buy) |
|
Details | ||
| 1/22/2025 | Edgewise Therapeutics | EWTX | New Coverage | Hold (N/A) |
26.26 (39.76) |
51.41% | Details | |
| 1/22/2025 | Cytokinetics | CYTK | New Coverage | Buy (N/A) |
45.74 (80.18) |
75.3% | Details |
